Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

FDA Admits Vaping Is Safer Than Smoking But Refuses To Correct the Record

Don’t expect a change in course, despite the long-awaited admission.

Reason

Civil service union urges honesty on public sector cuts amid austerity fears

Departments report being asked to find ways to reduce borrowing after Kwasi Kwarteng’s mini-budget

The Guardian - UK

Another prospect for an Alzheimer's drug renews cost concerns

But positive clinical trial results also renew the hopes of millions of seniors.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

This company is bioengineering pig kidneys and livers for possible transplant into humans

In an Minnesota lab, clear containers hold pig kidneys and livers that scientists hope will someday be transplantable in humans.

Tribune News Service

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win

Eli Lilly And Co (NYSE:LLY) - Market cap: $295 billion.

Benzinga

FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator

The FDA has appointed Norman Birenbaum to be the its senior public health advisor on cannabis research and regulatory actions,

Benzinga

7 Biogen Analysts On Alzheimer's Drug Success As Stock Skyrockets 37%

Shares of Biogen Inc (NASDAQ: BIIB) were flying on Wednesday, after the biopharma company said its experimental Alzheimer’s drug with Japanese partner Eisai showed promising results. RBC Capital Markets On Biogen

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Benzinga

World's first EVER drug shown to work against Alzheimer's developed by scientists

Scientists say the development of the only drug to work against Alzheimer’s is a 'historic moment' - with regulators expected to approve the groundbreaking drug by the New Year

Daily Mirror

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Gainers

Benzinga

Stopgap funding measure back on track after Manchin concession on permitting

WASHINGTON — The path to averting a partial government shutdown by Friday night just became a little easier to see, after Senate Democrats said they'd drop a contentious environmental policy rider that had drawn critiques from the right and left.

Tribune News Service

Starbucks customer stuns with 20 espresso shots order in one drink: ‘Is she ok?’

One Starbucks shot of espresso contains 75 milligrams of caffeine

The Independent UK

Nasdaq Turns Higher; Crude Oil Rises Over 2%

U.S. stocks pared some losses toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Benzinga

US Stocks Turn Lower; Dow Dips 175 Points

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 175 points on Tuesday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Benzinga

US Stocks Open Higher; Dow Surges 300 Points

U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.

Benzinga

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.

Benzinga

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday

Gainers

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Tesla safety ‘recall’ to be fixed with software update

Tesla CEO insists the recent problem with its car windows is merely a patch. Who is right?

Mic

How does online ADHD testing work? Safe Haven uses FDA-cleared devices without an appointment

We only recommend products we love and that we think you will, too. We may receive a portion of sales from products purchased from this article, which was written by our Commerce team.

Benzinga

Bloomberg

Los Angeles Times

Commentary: Prevent a legal Catch-22 that could push thousands of generic drugs off the market

Carvedilol could be the poster child for how to lower drug prices. Since 2007, more than 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared with $4.81 for the brand-name product. Patents on the drug Coreg, dating back…

Inverse

Is ketamine the secret to treating depression? Studies reveal its potential

Ketamine is becoming a mainstream in the world of mental health and a slew of new research suggests it has real potential to treat conditions like depression.

Tribune News Service

Hemp-derived delta-8 skirts marijuana laws and raises health concerns

Suzan Kennedy has smoked marijuana, and says her Wisconsin roots mean she can handle booze, so she was not concerned earlier this year when a bartender in St. Paul, Minnesota, described a cocktail with the cannabinoid delta-8 THC as “a little bit potent.”

Boston Herald

‘If not for the Ice Bucket Challenge, we wouldn’t be here’: Cambridge company on the brink of FDA-approved ALS treatment

BOSTON — Eight years after the ALS Ice Bucket Challenge went viral across social media and raised hundreds of millions of dollars for research, a Cambridge company is on the brink of a major breakthrough for ALS patients.

1 … 187 188 189 190

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.